Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer (Q43698942)
Jump to navigation
Jump to search
scientific article published in August 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer |
scientific article published in August 2001 |
Statements
1 reference
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer (English)
1 reference
Schmalfeldt B
1 reference
Prechtel D
1 reference
Härting K
1 reference
Späthe K
1 reference
Rutke S
1 reference
Konik E
1 reference
Fridman R
1 reference
Berger U
1 reference
Schmitt M
1 reference
Kuhn W
1 reference
Lengyel E
1 reference
1 August 2001
1 reference
1 reference
7
1 reference
8
1 reference
2396-2404
1 reference
Identifiers
1 reference